SCHEMBL22798240

SCHEMBL22798240

CC(=O)Nc1cc(C(=O)NCCOc2ccc(OC(F)(F)F)cc2Cl)cc(C)n1

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 1/20 0.51
ADORA3 P0DMS8 1/20 0.44
PPARD Q03181 1/20 0.42
PPARA Q07869 1/20 0.42
MCHR1 Q99705 1/20 0.42
RIPK1 Q13546 5/20 0.41
MRGPRX4 Q96LA9 2/20 0.41
TRPV1 Q8NER1 4/20 0.41
FFAR1 O14842 1/20 0.41
FFAR4 Q5NUL3 1/20 0.41
S1PR4 O95977 1/20 0.39
RHOC P08134 1/20 0.39
RHOA P61586 1/20 0.39
KDM4E B2RXH2 1/20 0.39
MEN1 O00255 1/20 0.39
MAPK1 P28482 1/20 0.39
KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22797829 0.91 SCN9A (0.49) SCN9AADORA3PPARDPPARAMCHR1
SCHEMBL22809629 0.91 SCN9A (0.46) SCN9AADORA3PPARDPPARAMCHR1
SCHEMBL20596684 0.91 SCN9A (0.63) SCN9AADORA3PPARDPPARAMCHR1
SCHEMBL20595232 0.90 SCN9A (0.48) SCN9APPARDPPARAMCHR1MRGPRX4
SCHEMBL20595174 0.87 SCN9A (0.51) SCN9AADORA3PPARDPPARAMCHR1
SCHEMBL22797791 0.87 SCN9A (0.61) SCN9AMRGPRX4RHOCRHOA
SCHEMBL22797759 0.85 MAPT (0.48) SCN9AADORA3MCHR1RIPK1MEN1
SCHEMBL20595201 0.85 SCN9A (0.46) SCN9AADORA3RIPK1RHOCRHOA
SCHEMBL22798289 0.81 SCN9A (0.54) SCN9AADORA3PPARDPPARAMRGPRX4
SCHEMBL22798305 0.80 SCN9A (0.56) SCN9AADORA3RHOCRHOAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110612285-B Amide derivatives as Nav1.7 and Nav1.8 blockers 拉夸里亚创药株式会社 2023-04-04 CN claimed
US-11154544-B2 Amide derivatives as Nav1.7 and Nav1.8 blockers RAQUALIA PHARMA INC. (JP) 2021-10-26 US claimed
EP-3487839-B1 AMIDE DERIVATIVES AS NAV1.7 AND NAV1.8 BLOCKERS RAQUALIA PHARMA INC (JP) 2020-12-23 EP claimed
CN-110612285-A Amide derivatives as Nav1.7 and Nav1.8 blockers 拉夸里亚创药株式会社 2019-12-24 CN claimed
CN-110612285-B Amide derivatives as Nav1.7 and Nav1.8 blockers 拉夸里亚创药株式会社 2023-04-04 CN disclosed
US-11154544-B2 Amide derivatives as Nav1.7 and Nav1.8 blockers RAQUALIA PHARMA INC. (JP) 2021-10-26 US disclosed
CN-110612285-A Amide derivatives as Nav1.7 and Nav1.8 blockers 拉夸里亚创药株式会社 2019-12-24 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11154544-B2 Amide derivatives as Nav1.7 and Nav1.8 blockers SCN8A, SCN7A, SCN1A SCN9A 9/4885ADORA3 2236/4885PPARD 2238/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.